A Study to Evaluate GSK Biologicals' Candidate Formulations of Pneumococcal Vaccines (GSK2189241A) in Elderly Subjects.
Phase of Trial: Phase I
Latest Information Update: 16 May 2017
At a glance
- Drugs Pneumococcal vaccine (Primary)
- Indications Pneumococcal infections
- Focus Adverse reactions
- Sponsors GlaxoSmithKline
- 10 Jun 2009 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 10 Jun 2009 Actual end date (1 May 2009) added as reported by ClinicalTrials.gov.
- 19 Feb 2009 Actual patient numbers (135) added as reported by ClinicalTrials.gov.